Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016662
Filing Date
2019-05-08
Accepted
2019-05-07 17:59:08
Documents
97
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q_20190331 mygn-10q_20190331.htm 10-Q 3419793
2 EX-31.1 mygn-ex311_6.htm EX-31.1 15851
3 EX-31.2 mygn-ex312_8.htm EX-31.2 16319
4 EX-32.1 mygn-ex321_7.htm EX-32.1 6519
  Complete submission text file 0001564590-19-016662.txt   13509803

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mygn-20190331.xml EX-101.INS 3794114
6 XBRL TAXONOMY EXTENSION SCHEMA mygn-20190331.xsd EX-101.SCH 66424
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20190331_cal.xml EX-101.CAL 78855
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20190331_def.xml EX-101.DEF 218343
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20190331_lab.xml EX-101.LAB 495956
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20190331_pre.xml EX-101.PRE 399338
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 19804443
SIC: 2835 In Vitro & In Vivo Diagnostic Substances